Kenneth Edwin Schmader, MD

Professor of Medicine
Director of the GRECC and ACOS for Geriatrics and Extended Care
Senior Fellow in the Center for the Study of Aging and Human Development
Campus mail Duke Box 3469, Durham, NC 27710
Phone (919) 660-7572
Email address schma001@mc.duke.edu

Dr. Schmader's primary area of research is herpes zoster and postherpetic neuralgia (PHN) and vaccines in older adults. He conducts pre-clinical, epidemiological and intervention studies of zoster and PHN, particularly with the zoster and influenza vaccines. He is involved with other adult vaccine development in older adults. With colleagues in the Division of Infectious Diseases, Dr. Schmader investigates other infections in older adults.

Another major research focus is adverse drug reactions, medication prescribing and pharmacoepidemiology in the elderly. The objective of the medication work is to reduce adverse drug reactions, improve inappropriate prescribing and determine drug use patterns in the elderly.

Education and Training

  • Fellow in Geriatrics, Medicine, Duke University, 1986 - 1988
  • Chief Medical Resident, Medicine, University of Wisconsin at Madison, 1983 - 1983
  • Medical Resident, Medicine, University of Wisconsin at Madison, 1980 - 1983
  • M.D., Wake Forest University, 1980

Publications

Dworkin, R. H., D. Carrington, A. Cunningham, R. G. Kost, M. J. Levin, M. W. McKendrick, M. N. Oxman, et al. “Assessment of pain in herpes zoster: lessons learned from antiviral trials..” Antiviral Res 33, no. 2 (January 1997): 73–85.

PMID
9021049
Scholars@Duke

Hanlon, J. T., P. B. Landsman, K. Cowan, K. E. Schmader, M. Weinberger, K. M. Uttech, G. P. Samsa, and H. J. Cohen. “Physician agreement with pharmacist-suggested drug therapy changes for elderly outpatients..” Am J Health Syst Pharm 53, no. 22 (November 15, 1996): 2735–37. https://doi.org/10.1093/ajhp/53.22.2735.

PMID
8931817
Full Text

Koenig, H. G., D. Wildman-Hanlon, and K. Schmader. “Attitudes of elderly patients and their families toward physician-assisted suicide..” Arch Intern Med 156, no. 19 (October 28, 1996): 2240–48.

PMID
8885824
Scholars@Duke

Hanlon, J. T., L. R. Landerman, W. E. Wall, R. D. Horner, G. G. Fillenbaum, D. V. Dawson, K. E. Schmader, H. J. Cohen, and D. G. Blazer. “Is medication use by community-dwelling elderly people influenced by cognitive function?.” Age Ageing 25, no. 3 (May 1996): 190–96. https://doi.org/10.1093/ageing/25.3.190.

PMID
8670550
Full Text

Hanlon, J. T., M. Weinberger, G. P. Samsa, K. E. Schmader, K. M. Uttech, I. K. Lewis, P. A. Cowper, P. B. Landsman, H. J. Cohen, and J. R. Feussner. “A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy..” Am J Med 100, no. 4 (April 1996): 428–37. https://doi.org/10.1016/S0002-9343(97)89519-8.

PMID
8610730
Full Text

Scott, M. A., J. T. Hanlon, P. S. Shelton, I. K. Lewis, K. E. Schmader, and P. B. Landsman. “Appropriateness of therapy with angiotensin-converting-enzyme inhibitors in elderly outpatients..” Am J Health Syst Pharm 53, no. 4 (February 15, 1996): 410–13. https://doi.org/10.1093/ajhp/53.4.410.

PMID
8673662
Full Text

Schmader, K., S. C. Henry, R. J. Rahija, Y. Yu, G. G. Daley, and J. D. Hamilton. “Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland..” J Infect Dis 172, no. 2 (August 1995): 531–34. https://doi.org/10.1093/infdis/172.2.531.

PMID
7622898
Full Text

Corder, E. H., A. M. Saunders, W. J. Strittmatter, D. E. Schmechel, P. C. Gaskell, J. B. Rimmler, P. A. Locke, P. M. Conneally, K. E. Schmader, and R. E. Tanzi. “Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease..” Neurology 45, no. 7 (July 1995): 1323–28. https://doi.org/10.1212/wnl.45.7.1323.

PMID
7617191
Full Text

Pages